Back to Search
Start Over
5-Hydroxytryptophan: A precursor of serotonin influences regional blood-brain barrier breakdown, cerebral blood flow, brain edema formation, and neuropathology.
- Source :
-
International review of neurobiology [Int Rev Neurobiol] 2019; Vol. 146, pp. 1-44. Date of Electronic Publication: 2019 Jul 18. - Publication Year :
- 2019
-
Abstract
- 5-Hydroxytryptophan (5-HTP), a precursor of serotonin, is therapeutically used for several psychiatric disorders such as anxiety and depression in the clinic. However, severe side effects, including abnormal mental functions, behavioral disturbances and intolerance are associated with this treatment. 5-HTP-induced elevation of plasma and brain serotonin levels may affect blood-brain barrier (BBB) breakdown, edema formation and regional cerebral blood flow (CBF) disturbances. Breakdown of BBB to serum proteins leads to vasogenic brain edema formation and cellular injuries. However, 5-HTP-neurotoxicity is still not well known. In this investigations 5-HTP induced elevation of endogenous plasma and brain serotonin levels and its effect on BBB breakdown, edema formation neuronal injuries was examined in a rat model. Furthermore, potential role of oxidative stress and nitric oxide (NO) was evaluated. In addition, several neurochemical agents such as p-CPA (5-HT synthesis inhibitor) indomethacin (prostaglandin synthase inhibitor), diazepam (ant stress drug), cyproheptadine, ketanserin (5-HT2 receptor antagonists) and vinblastine (inhibitor of microtubule function) were examined on 5-HT neurotoxicity. Our observations suggest that 4h after 5-HTP administrations, the endogenous serotonin levels increased by fourfold (150mg/kg) in the plasma and brain associated with profound hyperthermia (+3.86±0.24°C, oxidative stress and NO upregulation. Breakdown of the BBB to Evans blue albumin (EBA) in 8 brain regions and to <superscript>[131]</superscript> Iodine in 14 brain regions was observed. The CBF exhibited marked reduction in all the brain regions examined. Brain edema and cellular injuries are present in the areas associated with BBB disruption. Drug treatments reduced the BBB breakdown, edema formation NO production and brain pathology. These observations are the first to point out that 5-HTP-neurotoxicity caused by BBB breakdown, edema formation and NO production is instrumental in causing adverse mental and behavioral abnormalities, not reported earlier.<br /> (© 2019 Elsevier Inc. All rights reserved.)
- Subjects :
- 5-Hydroxytryptophan antagonists & inhibitors
Albumins metabolism
Animals
Behavior, Animal drug effects
Brain metabolism
Brain pathology
Brain Edema chemically induced
Cyproheptadine pharmacology
Diazepam pharmacology
Fenclonine pharmacology
Indomethacin pharmacology
Ketanserin pharmacology
Male
Nitric Oxide Synthase Type I metabolism
Rats
Serotonin blood
Serotonin metabolism
Vinblastine pharmacology
5-Hydroxytryptophan adverse effects
Blood-Brain Barrier drug effects
Brain Edema pathology
Cerebrovascular Circulation drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 2162-5514
- Volume :
- 146
- Database :
- MEDLINE
- Journal :
- International review of neurobiology
- Publication Type :
- Academic Journal
- Accession number :
- 31349924
- Full Text :
- https://doi.org/10.1016/bs.irn.2019.06.005